Xcout Intel
CELLBXHEALTH PLC competitors & alternatives
The 12 closest competitors and alternatives to CELLBXHEALTH PLC among biotech companies — ranked by similarity to what CELLBXHEALTH PLC actually does, not by market-cap band.
Subscribe to see CELLBXHEALTH PLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About CELLBXHEALTH PLC
CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.
CELLBXHEALTH PLC at a glance
CELLBXHEALTH PLC is a biotech company headquartered in Guildford, United Kingdom, founded in 2003. It is publicly listed (CLBX) with a market capitalisation of $20.4M. Xcout tracks 8 named people at CELLBXHEALTH PLC, including Michelle Munson (Chief of Staff).
CELLBXHEALTH PLC leadership
- Michelle MunsonChief of Staff
- Dr Jan GroenExecutive Chairman
- Sinéad ArmstrongFinance Director
- Christina DorrisVice President Commercial
- Lavanya SivapalanHead of R&D
- Boer Klaas deNon-executive Director and NomRemCo Chair
2 more named people on record for CELLBXHEALTH PLC, with roles, board committees and tenure — see the full roster →
Top 12 CELLBXHEALTH PLC competitors
Ranked by semantic similarity — how close each company is to CELLBXHEALTH PLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Biotechnology
Royal Biotech Inc. develops, manufactures, and markets portable diagnostic analysis products, handheld systems, and test kits for clinical, veterinary, food safety, and environmental applications. The company serves public security and health sectors by providing molecular and microfluidic diagnostic devices designed for on-site use.
Healthcare Diagnostics
Smart Health Diagnostics Co. operates as a healthcare diagnostics holding company that oversees specialized portfolio businesses focused on pathology, oncology, and vascular diagnostics. The company provides slide-free digital pathology technology through its MUSE microscopy system and offers vascular diagnostic tools like SmartVascular Dx to detect vascular inflammation for clinicians and healthcare systems.
Biotechnology & Medical Diagnostics
Biocare Medical develops and supplies advanced staining instruments, primary antibodies, and detection reagents for immunohistochemistry (IHC), in situ hybridization (ISH), and fluorescence in situ hybridization (FISH). The company serves clinical laboratories, research facilities, and pathologists by providing integrated automated staining platforms and testing solutions.
Medical - Diagnostics & Research
BioRegenx, Inc. develops, manufactures, and sells medical test equipment and science-based nutritional products in the United States and internationally. The company offers Endocalyx Pro, a dietary supplement targeting microvascular capillary health and a range of other supplements under the MyBodyRx brand name; GlycoCheck software; and other health and wellness devices, such as pulsed electro-magnetic field devices, as well as StimaWELL and ReLounge, an electronic muscle stimulation therapy device; and markets hydrogen water products. It also develops TruScan.Ai mobile app/website that integrates additional health indicators; and VitalWellness app, which merge its DNA and epigenetics platform. In addition, the company operates a social media content management platform, including its interactive search engine. Further, it provides DocSun Artificial Intelligence (AI) Engine, which integrates advanced ballistocardiography that detects an individual's heartbeat without touch; photoplethysmography, a method that uses light to track the flow of blood; and distributes wellness devices. The company sells its products through a direct selling channel to health professionals and research organizations. BioRegenx, Inc. is headquartered in Chattanooga, Tennessee.
Biotechnology
CyVek is a biotechnology and medical device company established in 2010 and headquartered in Wallingford, Connecticut. The company developed the CyPlex immunoassay technology, which integrates a microfluidic cartridge platform for measuring biological markers in the life sciences sector.
Biotechnology
TopoDx, Inc. is a diagnostic company founded in 2024 and headquartered in Atlanta, Georgia. The company operates in the medical diagnostics sector.
Medical - Diagnostics & Research
Check-Cap Ltd. is a medical diagnostics entity currently in its clinical development phase, dedicated to advancing screening solutions that utilize capsule-based technology. This firm was established in 2004 and conducts its primary operations from Isfiya, Israel.
Healthtech
PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.
Healthtech
iSono Health, Inc. specializes in automated breast imaging technology and provides diagnostic tools such as its FDA-cleared ATUSA system.
Biotechnology
Cizzle Biotechnology Holdings Plc specializes in developing an advanced immunoassay diagnostic test. This innovative tool aims to identify the CIZ1B biomarker, facilitating the early detection of lung cancer. The company, previously known as Cizzle Biotechnology Limited, officially changed its corporate identity to Cizzle Biotechnology Holdings Plc in May 2021. Its main operational base is situated in London, United Kingdom.
Biotechnology & Healthcare
CubeBio Holdings Ltd is an in vitro diagnostics company that develops non-invasive cancer screening solutions using urine samples. The company manufactures colorimetric reagents, spectrophotometric cuvettes, electrochemical biosensors, and diagnostic equipment to detect cancer biomarkers.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of CELLBXHEALTH PLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CELLBXHEALTH PLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →